Abstract Body

Background: Immune activation is a proposed mechanism for increased cardiac risk in HIV infection. We hypothesize that virally suppressed HIV-infected patients have higher CD8+ T cell and monocyte activation than uninfected controls, and that these measures are associated with coronary atherosclerosis. Methodology: Cross-sectional analyses of HIV-uninfected (n=71) and virally suppressed HIV-infected (n=95) men in Los Angeles, in the Multicenter AIDS Cohort Study (MACS). Non-contrast cardiac computed tomography (CT) for presence of coronary artery calcium (CAC) and CT angiograms for presence of calcified plaque (CP), mixed plaque (MP), non-calcified plaque (NCP) and total plaque (TP) were performed. CD8+ T cell activation (CD38+/HLADR+) was assessed by flow cytometry and soluble monocyte activation markers, sCD163 and sCD14 by ELISA. Associations between immune activation and presence of atherosclerosis were assessed with logistic regression, adjusting for age, ethnicity and cardiovascular risk factors. Results: Characteristics, CT and immune marker findings are in Table. HIV-infected men were younger with significantly higher CD8+ T cell activation and plasma sCD14 and sCD163 levels than HIV-uninfected men. There was no evidence for a relationship between CD8+ T cell activation and presence of any type of plaque (P>0.05 for all) in either group. In HIV-uninfected both sCD163 and sCD14 were associated with presence of CAC, adjusted odds ratio [aOR] (95% confidence interval [CI]) 1.82 (1.04, 4.28) and 1.36 (1.01, 2.05), as well as CP, 2.53 (1.37, 6.42) and 1.67 (1.21, 2.67), respectively. For HIVinfected men, sCD14 was not associated with presence of atherosclerosis but sCD163 was for CP, MP and TP with aOR (95% CI) of 1.28 (1.01, 1.66), 1.45 (1.13, 1.91) and 1.56 (1.13, 2.32), respectively. Conclusions: Virally suppressed HIV-infected men had significantly higher CD8+ T cell and monocyte activation than HIV-uninfected men. CD8+ T cell activation was not associated with coronary atherosclerosis in either group. In contrast, the monocyte activation markers sCD14 and sCD163 were associated with coronary calcium and calcified plaque in HIV-uninfected while sCD163 but not sCD14 were associated with presence of calcified, mixed and total plaque in HIV-infected. Further study is needed to define the mechanism behind increased immune activation in virally suppressed HIV-infected patients and the role monocyte activation plays in coronary atherosclerosis.